Finally, these studies also reveal that increasing FOXA2 levels in islets with reduced mTORC1 activity rescue PDX1 levels and insulin secretion, highlighting the importance of the AKT/FOXA2/PDX1 axis as a possible therapeutic tool to improve β-cells in conditions of insulin resistance. The gene discussed is FOXA2; the disease is Insulin resistance.